InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,129.60
(
-0.24%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.18
(
-0.35%
)
Bitcoin
60,955.97
(
0.24%
)

Replies to post #125975 on Innovation Pharmaceuticals Inc (IPIX)

Replies to #125975 on Innovation Pharmaceuticals Inc (IPIX)

noretreat

10/15/15 4:24 PM

#125983 RE: rule_rationale #125975

so we agree...up to 6 months for a headline like this:


"Cellceutix reports Kevetrin meets all primary and secondary endpoints in Phase 1 study at Dana-Farber"

I like it so much I want to repeat it:

"Cellceutix reports Kevetrin meets all primary and secondary endpoints in Phase 1 study at Dana-Farber"